A potential ‘home run’ trade is emerging in this pharma stock

A potential ‘home run’ trade is emerging in this pharma stock

I recently laid out a bullish thesis for Gilead Sciences (GILD) , and that trade just expired on Friday with a 144% gain. The bullish debit vertical spread successfully captured the upside to a new 52-week high as sentiment improved around Gilead’s strengthening HIV franchise and expanding oncology portfolio. I’m looking to roll our profits into a new bullish…

Read More
Jim Cramer says strong earnings from ‘actual businesses’ are driving the ‘real economy’

Jim Cramer says strong earnings from ‘actual businesses’ are driving the ‘real economy’

Jim Cramer on Mad Money, June 14, 2022. Scott Mlyn | CNBC Despite all eyes on the Magnificent Seven, CNBC’s Jim Cramer said that strong earnings results from companies in the “real economy” were responsible for Tuesday’s rally. “We got some tremendous numbers from actual businesses,” Cramer said. “And I think we need to celebrate…

Read More